Topic

Conditions

How myostatin drives muscle loss across disease — cachexia, sarcopenia, kidney disease, diabetes, heart failure, Duchenne, and aging.

11 articles

What Bed Rest Does to Your Myostatin (and Muscle) cover
May 22, 202611 min read

What Bed Rest Does to Your Myostatin (and Muscle)

Bed rest is not rest. After three days of immobility, myostatin transcription climbs, atrogenes light up, and muscle starts breaking down faster than calories can fix.

Myostatin and Heart Failure: Cardiac vs Skeletal Muscle cover
May 22, 202611 min read

Myostatin and Heart Failure: Cardiac vs Skeletal Muscle

Myostatin behaves differently in cardiac muscle than in skeletal muscle. The failing heart secretes it. Skeletal muscle gets the worst of it. Blocking it everywhere is harder than it sounds.

Myostatin, Insulin Resistance, and Type 2 Diabetes cover
May 22, 202611 min read

Myostatin, Insulin Resistance, and Type 2 Diabetes

Myostatin is a muscle gene, but its effects spill into insulin signaling, glucose uptake, and metabolic syndrome. People with high serum myostatin look insulin-resistant before the diabetes label arrives.

Myostatin in Chronic Kidney Disease: The Dialysis Muscle-Loss Connection cover
May 22, 202611 min read

Myostatin in Chronic Kidney Disease: The Dialysis Muscle-Loss Connection

CKD does not just damage kidneys. It rewires muscle protein turnover through a uremic environment that drives myostatin up, IGF-1 down, and lean mass into ongoing decline.

Myostatin and Cancer Cachexia: Why Muscle Wasting Resists Calories cover
May 22, 202611 min read

Myostatin and Cancer Cachexia: Why Muscle Wasting Resists Calories

Cancer cachexia is not starvation. Patients who eat enough still lose muscle, and myostatin and its sibling activin A are central to why food alone cannot stop it.

Myostatin and Duchenne Muscular Dystrophy: What the Trials Showed cover
May 22, 202612 min read

Myostatin and Duchenne Muscular Dystrophy: What the Trials Showed

Duchenne muscular dystrophy was supposed to be the disease that proved myostatin inhibitors. Eight programs, three sponsors, and one common failure pattern later, the field is still trying.

Myostatin Deficiency in Humans: The German Baby, Liam Hoekstra, and What the Gene Does cover
May 18, 20269 min read

Myostatin Deficiency in Humans: The German Baby, Liam Hoekstra, and What the Gene Does

Myostatin deficiency in humans is rare, real, and often oversold. A German baby, an American toddler, and a 2026 UK Biobank study now anchor what we actually know.

Myostatin and Aging: How GDF-8 Changes From Your 30s to Your 70s cover
May 18, 20269 min read

Myostatin and Aging: How GDF-8 Changes From Your 30s to Your 70s

Myostatin and aging is not a clean upward line. Lean mass drops, anabolic resistance climbs, and GDF-8 only tells part of the sarcopenia story.

Myostatin in Women: Why Female Muscle Biology Reads Differently cover
May 18, 20269 min read

Myostatin in Women: Why Female Muscle Biology Reads Differently

Myostatin in women behaves differently than the gym-bro story suggests. Reproduction, the menstrual cycle, PCOS, and menopause all shift the picture.

Myostatin Blood Test: Where to Get One and What the Result Means cover
May 18, 20269 min read

Myostatin Blood Test: Where to Get One and What the Result Means

A myostatin blood test sounds straightforward, but the assays measure different things, the reference ranges are shaky, and the most useful number is the follistatin-to-myostatin ratio. Here is what each available option actually delivers.

Myostatin and Sarcopenia: Why Muscle Loss Accelerates After 60 cover
May 16, 20269 min read

Myostatin and Sarcopenia: Why Muscle Loss Accelerates After 60

Myostatin is one of the clearest age-related muscle-loss biomarkers, and it explains why sarcopenia accelerates after 60. Here is what circulating GDF-8 actually does, what trials of myostatin drugs found, and what works right now.